During the last session, Redhill Biopharma Ltd. ADR (NASDAQ:RDHL)’s traded shares were 6.25 million, with the beta value of the company hitting 4.30. At the end of the trading day, the stock’s price was $2.07, reflecting an intraday loss of -3.04% or -$0.06. The 52-week high for the RDHL share is $20.27, that puts it down -879.23 from that peak though still a striking 13.04% gain since the share price plummeted to a 52-week low of $1.80. The company’s market capitalization is $2.63M, and the average intraday trading volume over the past 10 days was 0.67 million shares, and the average trade volume was 94.19K shares over the past three months.
Redhill Biopharma Ltd. ADR (NASDAQ:RDHL) trade information
Redhill Biopharma Ltd. ADR (RDHL) registered a -3.04% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -3.04% in intraday trading to $2.07, hitting a weekly high. The stock’s 5-day price performance is -23.33%, and it has moved by -27.62% in 30 days. Based on these gigs, the overall price performance for the year is -79.52%. The short interest in Redhill Biopharma Ltd. ADR (NASDAQ:RDHL) is 29973.0 shares and it means that shorts have 0.26 day(s) to cover.
RDHL Dividends
Redhill Biopharma Ltd. ADR is due to release its next quarterly earnings on 2022-Nov-06. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Data provided on Sep 30, 2024 indicates that Fidelity NASDAQ Composite Index Fund owns about 41.0 shares. This amounts to just over 0.00 percent of the company’s overall shares, with a $84.0 market value.
